- Yale DermatologyYale Dermatology - Branford322 East Main StreetBranford, CT 06405
- Photopheresis UnitHunter Building15 York Street, Fl 4thNew Haven, CT 06510
Ian Odell, MD, PhD, FAAD
Biography
Dermatologist Ian D. Odell, MD, PhD, enjoys improving the quality of his patients’ lives. “If it's a minor complaint, I strive to help make it go away,” he says. “If it’s a complex or difficult medical problem, I aim to find the best treatment that has the least risk.”
Dr. Odell also learns from the people he cares for each day. “I love that while I take care of patients, they also teach me about their conditions,” Dr. Odell says. “Patients themselves teach us so much about how the body works. The skin problems they run into shed light on fundamental biological concepts that we wouldn't otherwise know about.”
As a clinician, he treats a wide variety of skin concerns, including skin cancer, acne, eczema and rare autoimmune diseases that manifest themselves in the skin. He's also researcher and an instructor at Yale School of Medicine where he studies autoimmune diseases in the laboratory, including scleroderma (systemic sclerosis) and chronic graft-versus-host disease. His research focuses on the role of the immune system in these two diseases, which cause hardness and tightening of the skin and can progress to the internal organs without proper treatment.
Titles
- Assistant Professor of Dermatology
- Dermatology Director, Adult Primary Care Center
Education & Training
- Research FellowshipYale University (2017)
- ResidencyYale University (2016)
- InternshipUniversity of Vermont (2013)
- MDUniversity of Vermont (2012)
- PhDUniversity of Vermont, Microbiology and Molecular Genetics (2011)
- Bachelor of ArtsCornell University (2005)
Languages Spoken
- English
- Español (Spanish)
Additional Information
- Dr. Philip Moskowitz Prize for achievements in the field of Autoimmunity: Colton Center for Autoimmunity (2022)
- 2022 Young Physician-Scientist Award: American Society for Clinical Investigation (2022)
- YCCI Scholar Award: Yale Center for Clinical Investigation (2017)
- Career Development Award: Dermatology Foundation (2017)
- Dermatologist Investigator Research Fellowship: Dermatology Foundation (2016)
- AB of Dermatology, Dermatology (2016)
- Xie CB, Cowper S, Odell ID. Morphea after Borrelia-induced facial nerve palsy. Journal Of Scleroderma And Related Disorders 2020, 6: 111-113. PMID: 35382252, PMCID: PMC8922639, DOI: 10.1177/2397198320956892.
- Kim DJ, Odell ID. Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections. JAAD Case Reports 2022, 26: 79-81. PMID: 35942355, PMCID: PMC9356022, DOI: 10.1016/j.jdcr.2022.06.009.
- Odell ID, Flavell RA, Silver FH. Vibrational optical coherence tomography detects unique skin fibrotic states: Preliminary results of animal and human studies. Journal Of The American Academy Of Dermatology 2020, 85: 780-782. PMID: 32860914, PMCID: PMC9793292, DOI: 10.1016/j.jaad.2020.08.091.
- Odell I, Steach H, Gauld S, Reinke-Breen L, Karman J, Carr T, Wetter J, Phillips L, Hinchcliff M, Flavell R. Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis. Science Immunology 2022, 7: eabq6691-eabq6691. PMID: 36490328, PMCID: PMC9840167, DOI: 10.1126/sciimmunol.abq6691.
- Ryu S, Gauld S, Staron M, Odell I, Cash J, Radstake T. Editorial: Exploring immune-stromal cell dynamics: pathways and therapeutic implications. Frontiers In Immunology 2025, 16: 1744273. DOI: 10.3389/fimmu.2025.1744273.
- Odell A, Newton N, Eisenstein A, Micevic G, Flavell R, Odell I. 488 EGFR-STAT1 Pathway Drives Fibrosis Initiation in Fibroinflammatory Skin Diseases. Journal Of Investigative Dermatology 2025, 145: s352. DOI: 10.1016/j.jid.2025.10.500.
- Odell A, Newton N, Eisenstein A, Micevic G, Flavell R, Odell I. EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases. Nature Communications 2025, 16: 8969. PMID: 41068129, PMCID: PMC12511620, DOI: 10.1038/s41467-025-64648-9.
- Newton N, Agrawal K, Odell A, Tracy T, Hackett C, Eldrup A, Whitfield M, Martyanov V, Girardi M, Sefik E, Flavell R, Odell I. Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. Blood 2025, 146: 3201-3212. PMID: 40961242, PMCID: PMC12643462, DOI: 10.1182/blood.2025029836.
- Newton N, Odell A, Odell I. 1006 Reduction of type I interferon biomarkers by cGAS inhibition in scleroderma and GvHD skin. Journal Of Investigative Dermatology 2025, 145: s174. DOI: 10.1016/j.jid.2025.06.1023.
- Odell A, Newton N, Flavell R, Odell I. 0958 Nuclear epidermal growth factor receptor modulates skin laxity and fibrosis. Journal Of Investigative Dermatology 2025, 145: s166. DOI: 10.1016/j.jid.2025.06.974.
- Odell I, Newton N, Odell A, Girardi M, Flavell R. 1013 Sclerotic graft-vs-host disease shares dysregulated gene expression with scleroderma that can be targeted with epiregulin inhibition. Journal Of Investigative Dermatology 2025, 145: s175. DOI: 10.1016/j.jid.2025.06.1030.
- Sefik E, Xiao T, Chiorazzi M, Odell I, Zhang F, Agrawal K, Micevic G, Flavell R. Engineering Mice to Study Human Immunity. Annual Review Of Immunology 2025, 43: 451-487. PMID: 40020225, DOI: 10.1146/annurev-immunol-082523-124415.
- Caves E, Jussila A, Forni M, Benvie A, Lei V, King D, Edelman H, Hamdan M, Odell I, Hinchcliff M, Atit R, Horsley V. A tgl-Dependent Adipocyte Lipolysis Promotes Lipodystrophy and Restrains Fibrogenic Responses during Skin Fibrosis. Journal Of Investigative Dermatology 2025, 145: 1896-1909.e5. PMID: 39884454, DOI: 10.1016/j.jid.2024.12.022.
- Swallow M, Chang J, Carlson K, Odell I, Girardi M. Correction: Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease. Archives Of Dermatological Research 2025, 317: 534. PMID: 40056227, PMCID: PMC11890354, DOI: 10.1007/s00403-025-04005-4.
- Swallow M, Chang J, Carlson K, Odell I, Girardi M. Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease. Archives Of Dermatological Research 2025, 317: 298. PMID: 39833520, PMCID: PMC11753368, DOI: 10.1007/s00403-024-03770-y.
- Odell I. Genetic and molecular drivers of scleroderma pathogenesis. Clinics In Dermatology 2024, 43: 153-159. PMID: 39675445, PMCID: PMC12009687, DOI: 10.1016/j.clindermatol.2024.12.007.
- Ko C, Odell I, Gehlhausen J, Leventhal J, McNiff J, Zubek A. VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis. Journal Of Cutaneous Pathology 2024, 52: 108-112. PMID: 39610062, DOI: 10.1111/cup.14757.
- Odell I. Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases. Current Opinion In Rheumatology 2024, 36: 379-386. PMID: 39171604, PMCID: PMC11451931, DOI: 10.1097/bor.0000000000001047.
- Swallow M, Chang J, Carlson K, Odell I, Girardi M. LB931 Treatment of chronic graft-versus-host disease with combination extracorporeal photopheresis and the ROCK2 inhibitor belumosudil can reverse sclerodermatous changes. Journal Of Investigative Dermatology 2024, 144: s163. DOI: 10.1016/j.jid.2024.06.1104.
- Newton N, Odell A, Odell I. 029 Investigation of cGAS-STING signaling in scleroderma and GvHD Skin. Journal Of Investigative Dermatology 2024, 144: s5. DOI: 10.1016/j.jid.2024.06.045.
- Hinchcliff M, Wu M, Odell I, Papademetris X, Feher A, Zhao Y, Lee H, Lempel M, Wang A, Galiana G, Van Horn C, Gunes B, Kujawski S. POS0835 VOLUMETRIC QUANTIFICATION OF SYSTEMIC SCLEROSIS-ASSOCIATED CALCINOSIS CUTIS. Annals Of The Rheumatic Diseases 2024, 83: 1041-1042. DOI: 10.1136/annrheumdis-2024-eular.2060.
- Qu R, Cheng X, Sefik E, Stanley III J, Landa B, Strino F, Platt S, Garritano J, Odell I, Coifman R, Flavell R, Myung P, Kluger Y. Gene trajectory inference for single-cell data by optimal transport metrics. Nature Biotechnology 2024, 43: 258-268. PMID: 38580861, PMCID: PMC11452571, DOI: 10.1038/s41587-024-02186-3.
- Pellowe A, Wu M, Kang T, Chung T, Ledesma-Mendoza A, Herzog E, Levchenko A, Odell I, Varga J, Gonzalez A. TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease. American Journal Of Pathology 2024, 194: 1171-1184. PMID: 38548268, PMCID: PMC11220919, DOI: 10.1016/j.ajpath.2024.02.021.
- Odell I, Agrawal K, Sefik E, Odell A, Caves E, Kirkiles-Smith N, Horsley V, Hinchcliff M, Pober J, Kluger Y, Flavell R. IL-6 trans-signaling in a humanized mouse model of scleroderma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2023, 120: e2306965120. PMID: 37669366, PMCID: PMC10500188, DOI: 10.1073/pnas.2306965120.
- Fan R, Johnston MS, Gowen MF, Damsky W, Odell I, Clune J, Vesely MD. Amelanotic melanoma in a patient with Hermansky-Pudlak syndrome. JAAD Case Reports 2022, 27: 61-63. PMID: 35990226, PMCID: PMC9388864, DOI: 10.1016/j.jdcr.2022.06.035.
- Damsky W, Wang A, Kim DJ, Young BD, Singh K, Murphy MJ, Daccache J, Clark A, Ayasun R, Ryu C, McGeary MK, Odell ID, Fazzone-Chettiar R, Pucar D, Homer R, Gulati M, Miller EJ, Bosenberg M, Flavell RA, King B. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature Communications 2022, 13: 3140. PMID: 35668129, PMCID: PMC9170782, DOI: 10.1038/s41467-022-30615-x.
- Xie CB, Ring N, Damsky W, McNiff JM, Olino K, Odell I. Squamous cell carcinoma arising in long-standing necrobiosis lipoidica treated with radical resection and split-thickness skin graft. JAAD Case Reports 2021, 19: 90-93. PMID: 35024397, PMCID: PMC8724883, DOI: 10.1016/j.jdcr.2021.11.005.
- Sun Q, Gehlhausen JR, Freudzon M, Kibbi N, Bale A, Choate K, Tomayko M, Odell I, Ramachandran S. A novel NFkB1 mutation linking pyoderma gangrenosum and common variable immunodeficiency. JAAD Case Reports 2021, 18: 61-63. PMID: 34825039, PMCID: PMC8605275, DOI: 10.1016/j.jdcr.2021.10.015.
- Mendoza H, Goodwin J, Gehlhausen J, Odell I, McNiff J, Gnanapandithan K. New bullous lesions in a 72-year-old woman. Cleveland Clinic Journal Of Medicine 2021, 88: 319-324. PMID: 34078615, DOI: 10.3949/ccjm.88a.20180.
- Olamiju B, Odell I, Panse G, Eder JP, Leventhal JS. Skin puckering and edema during durvalumab therapy. JAAD Case Reports 2020, 7: 110-112. PMID: 33364282, PMCID: PMC7750709, DOI: 10.1016/j.jdcr.2020.11.019.
- Belzer A, Olamiju B, Antaya RJ, Odell ID, Bia M, Perkins SH, Cohen JM. A novel medical student initiative to enhance provision of teledermatology in a resident continuity clinic during the COVID‐19 pandemic: a pilot study. International Journal Of Dermatology 2020, 60: 128-129. PMID: 33226121, PMCID: PMC7753449, DOI: 10.1111/ijd.15322.
- Odell ID, Flavell RA. HER2 joins AKT to inhibit STING immunity. Nature Cell Biology 2019, 21: 917-918. PMID: 31371829, DOI: 10.1038/s41556-019-0368-4.
- Kibbi N, Totonchy M, Suozzi KC, Ko CJ, Odell ID. A case of subungual tumors of incontinentia pigmenti: A rare manifestation and association with bipolar disease. JAAD Case Reports 2018, 4: 737-741. PMID: 30167449, PMCID: PMC6113656, DOI: 10.1016/j.jdcr.2018.03.018.
- Odell ID, Flavell RA. Microbiome: Ecology of eczema. Nature Microbiology 2016, 1: 16135. PMID: 27562264, PMCID: PMC6035744, DOI: 10.1038/nmicrobiol.2016.135.
- Odell ID, Lilly E, Reeve K, Bosenberg MW, Milstone LM. Well-Differentiated Syringofibrocarcinoma in a Patient With Clouston Syndrome. JAMA Dermatology 2016, 152: 484. PMID: 26792110, DOI: 10.1001/jamadermatol.2015.4496.
- Leventhal JS, Odell ID, Imaeda S, Maverakis E, King BA. Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream. JAAD Case Reports 2016, 2: 114-116. PMID: 27051847, PMCID: PMC4810288, DOI: 10.1016/j.jdcr.2016.01.004.
- Shi VJ, Galan A, Odell ID, Choi JN. Cutaneous Vasculopathy as an Adverse Effect of the Anti–Vascular Endothelial Growth Factor Agent Axitinib. JAMA Dermatology 2016, 152: 222. PMID: 26509864, DOI: 10.1001/jamadermatol.2015.3209.
- Lim YH, Odell ID, Ko CJ, Choate KA. Somatic p.T771R KDR (VEGFR2) Mutation Arising in a Sporadic Angioma During Ramucirumab Therapy. JAMA Dermatology 2015, 151: 1240-1243. PMID: 26422291, DOI: 10.1001/jamadermatol.2015.1925.
- Odell ID, Zeidan AM, Parker TL, Colegio OR, Subtil A. Leukaemic vasculitis with myelodysplastic syndrome. The Lancet 2015, 386: 501-502. PMID: 26251396, DOI: 10.1016/s0140-6736(15)61165-5.
- Odell ID, Cook D. Optimizing Direct Immunofluorescence. Methods In Molecular Biology 2014, 1180: 111-117. PMID: 25015144, DOI: 10.1007/978-1-4939-1050-2_6.
- Odell ID, Cook D. Immunofluorescence Techniques. Journal Of Investigative Dermatology 2013, 133: 1-4. PMID: 23299451, DOI: 10.1038/jid.2012.455.
- Odell ID, Wallace SS, Pederson DS. Rules of engagement for base excision repair in chromatin. Journal Of Cellular Physiology 2012, 228: 258-266. PMID: 22718094, PMCID: PMC3468691, DOI: 10.1002/jcp.24134.
- Odell ID, Barbour JE, Murphy DL, Della-Maria JA, Sweasy JB, Tomkinson AE, Wallace SS, Pederson DS. Nucleosome Disruption by DNA Ligase III-XRCC1 Promotes Efficient Base Excision Repair. Molecular And Cellular Biology 2011, 31: 4623-4632. PMID: 21930793, PMCID: PMC3209256, DOI: 10.1128/mcb.05715-11.
- Odell ID, Newick K, Heintz NH, Wallace SS, Pederson DS. Non-specific DNA binding interferes with the efficient excision of oxidative lesions from chromatin by the human DNA glycosylase, NEIL1. DNA Repair 2009, 9: 134-143. PMID: 20005182, PMCID: PMC2829949, DOI: 10.1016/j.dnarep.2009.11.005.
- Hamilton B, Dong Y, Shindo M, Liu W, Odell I, Ruvkun G, Lee SS. A systematic RNAi screen for longevity genes in C. elegans. Genes & Development 2005, 19: 1544-1555. PMID: 15998808, PMCID: PMC1172061, DOI: 10.1101/gad.1308205.
- Odell ID, Cloud JL, Seipp M, Wittwer CT. Rapid Species Identification Within the Mycobacterium chelonae–abscessus Group by High-Resolution Melting Analysis of hsp65 PCR Products. American Journal Of Clinical Pathology 2005, 123: 96-101. PMID: 15762284, DOI: 10.1309/wdr082x9ffjbqqgb.
- Yale DermatologyYale Dermatology - Branford322 East Main StreetBranford, CT 06405
- Photopheresis UnitHunter Building15 York Street, Fl 4thNew Haven, CT 06510
Biography
Dermatologist Ian D. Odell, MD, PhD, enjoys improving the quality of his patients’ lives. “If it's a minor complaint, I strive to help make it go away,” he says. “If it’s a complex or difficult medical problem, I aim to find the best treatment that has the least risk.”
Dr. Odell also learns from the people he cares for each day. “I love that while I take care of patients, they also teach me about their conditions,” Dr. Odell says. “Patients themselves teach us so much about how the body works. The skin problems they run into shed light on fundamental biological concepts that we wouldn't otherwise know about.”
As a clinician, he treats a wide variety of skin concerns, including skin cancer, acne, eczema and rare autoimmune diseases that manifest themselves in the skin. He's also researcher and an instructor at Yale School of Medicine where he studies autoimmune diseases in the laboratory, including scleroderma (systemic sclerosis) and chronic graft-versus-host disease. His research focuses on the role of the immune system in these two diseases, which cause hardness and tightening of the skin and can progress to the internal organs without proper treatment.
Titles
- Assistant Professor of Dermatology
- Dermatology Director, Adult Primary Care Center
Education & Training
- Research FellowshipYale University (2017)
- ResidencyYale University (2016)
- InternshipUniversity of Vermont (2013)
- MDUniversity of Vermont (2012)
- PhDUniversity of Vermont, Microbiology and Molecular Genetics (2011)
- Bachelor of ArtsCornell University (2005)
Languages Spoken
- English
- Español (Spanish)
Additional Information
- Dr. Philip Moskowitz Prize for achievements in the field of Autoimmunity: Colton Center for Autoimmunity (2022)
- 2022 Young Physician-Scientist Award: American Society for Clinical Investigation (2022)
- YCCI Scholar Award: Yale Center for Clinical Investigation (2017)
- Career Development Award: Dermatology Foundation (2017)
- Dermatologist Investigator Research Fellowship: Dermatology Foundation (2016)
- AB of Dermatology, Dermatology (2016)
- Xie CB, Cowper S, Odell ID. Morphea after Borrelia-induced facial nerve palsy. Journal Of Scleroderma And Related Disorders 2020, 6: 111-113. PMID: 35382252, PMCID: PMC8922639, DOI: 10.1177/2397198320956892.
- Kim DJ, Odell ID. Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections. JAAD Case Reports 2022, 26: 79-81. PMID: 35942355, PMCID: PMC9356022, DOI: 10.1016/j.jdcr.2022.06.009.
- Odell ID, Flavell RA, Silver FH. Vibrational optical coherence tomography detects unique skin fibrotic states: Preliminary results of animal and human studies. Journal Of The American Academy Of Dermatology 2020, 85: 780-782. PMID: 32860914, PMCID: PMC9793292, DOI: 10.1016/j.jaad.2020.08.091.
- Odell I, Steach H, Gauld S, Reinke-Breen L, Karman J, Carr T, Wetter J, Phillips L, Hinchcliff M, Flavell R. Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis. Science Immunology 2022, 7: eabq6691-eabq6691. PMID: 36490328, PMCID: PMC9840167, DOI: 10.1126/sciimmunol.abq6691.
- Ryu S, Gauld S, Staron M, Odell I, Cash J, Radstake T. Editorial: Exploring immune-stromal cell dynamics: pathways and therapeutic implications. Frontiers In Immunology 2025, 16: 1744273. DOI: 10.3389/fimmu.2025.1744273.
- Odell A, Newton N, Eisenstein A, Micevic G, Flavell R, Odell I. 488 EGFR-STAT1 Pathway Drives Fibrosis Initiation in Fibroinflammatory Skin Diseases. Journal Of Investigative Dermatology 2025, 145: s352. DOI: 10.1016/j.jid.2025.10.500.
- Odell A, Newton N, Eisenstein A, Micevic G, Flavell R, Odell I. EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases. Nature Communications 2025, 16: 8969. PMID: 41068129, PMCID: PMC12511620, DOI: 10.1038/s41467-025-64648-9.
- Newton N, Agrawal K, Odell A, Tracy T, Hackett C, Eldrup A, Whitfield M, Martyanov V, Girardi M, Sefik E, Flavell R, Odell I. Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. Blood 2025, 146: 3201-3212. PMID: 40961242, PMCID: PMC12643462, DOI: 10.1182/blood.2025029836.
- Newton N, Odell A, Odell I. 1006 Reduction of type I interferon biomarkers by cGAS inhibition in scleroderma and GvHD skin. Journal Of Investigative Dermatology 2025, 145: s174. DOI: 10.1016/j.jid.2025.06.1023.
- Odell A, Newton N, Flavell R, Odell I. 0958 Nuclear epidermal growth factor receptor modulates skin laxity and fibrosis. Journal Of Investigative Dermatology 2025, 145: s166. DOI: 10.1016/j.jid.2025.06.974.
- Odell I, Newton N, Odell A, Girardi M, Flavell R. 1013 Sclerotic graft-vs-host disease shares dysregulated gene expression with scleroderma that can be targeted with epiregulin inhibition. Journal Of Investigative Dermatology 2025, 145: s175. DOI: 10.1016/j.jid.2025.06.1030.
- Sefik E, Xiao T, Chiorazzi M, Odell I, Zhang F, Agrawal K, Micevic G, Flavell R. Engineering Mice to Study Human Immunity. Annual Review Of Immunology 2025, 43: 451-487. PMID: 40020225, DOI: 10.1146/annurev-immunol-082523-124415.
- Caves E, Jussila A, Forni M, Benvie A, Lei V, King D, Edelman H, Hamdan M, Odell I, Hinchcliff M, Atit R, Horsley V. A tgl-Dependent Adipocyte Lipolysis Promotes Lipodystrophy and Restrains Fibrogenic Responses during Skin Fibrosis. Journal Of Investigative Dermatology 2025, 145: 1896-1909.e5. PMID: 39884454, DOI: 10.1016/j.jid.2024.12.022.
- Swallow M, Chang J, Carlson K, Odell I, Girardi M. Correction: Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease. Archives Of Dermatological Research 2025, 317: 534. PMID: 40056227, PMCID: PMC11890354, DOI: 10.1007/s00403-025-04005-4.
- Swallow M, Chang J, Carlson K, Odell I, Girardi M. Combination treatment of extracorporeal photopheresis and belumosudil for chronic graft-versus-host disease. Archives Of Dermatological Research 2025, 317: 298. PMID: 39833520, PMCID: PMC11753368, DOI: 10.1007/s00403-024-03770-y.
- Odell I. Genetic and molecular drivers of scleroderma pathogenesis. Clinics In Dermatology 2024, 43: 153-159. PMID: 39675445, PMCID: PMC12009687, DOI: 10.1016/j.clindermatol.2024.12.007.
- Ko C, Odell I, Gehlhausen J, Leventhal J, McNiff J, Zubek A. VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis. Journal Of Cutaneous Pathology 2024, 52: 108-112. PMID: 39610062, DOI: 10.1111/cup.14757.
- Odell I. Cross-tissue organization of myeloid cells in scleroderma and related fibrotic diseases. Current Opinion In Rheumatology 2024, 36: 379-386. PMID: 39171604, PMCID: PMC11451931, DOI: 10.1097/bor.0000000000001047.
- Swallow M, Chang J, Carlson K, Odell I, Girardi M. LB931 Treatment of chronic graft-versus-host disease with combination extracorporeal photopheresis and the ROCK2 inhibitor belumosudil can reverse sclerodermatous changes. Journal Of Investigative Dermatology 2024, 144: s163. DOI: 10.1016/j.jid.2024.06.1104.
- Newton N, Odell A, Odell I. 029 Investigation of cGAS-STING signaling in scleroderma and GvHD Skin. Journal Of Investigative Dermatology 2024, 144: s5. DOI: 10.1016/j.jid.2024.06.045.
- Hinchcliff M, Wu M, Odell I, Papademetris X, Feher A, Zhao Y, Lee H, Lempel M, Wang A, Galiana G, Van Horn C, Gunes B, Kujawski S. POS0835 VOLUMETRIC QUANTIFICATION OF SYSTEMIC SCLEROSIS-ASSOCIATED CALCINOSIS CUTIS. Annals Of The Rheumatic Diseases 2024, 83: 1041-1042. DOI: 10.1136/annrheumdis-2024-eular.2060.
- Qu R, Cheng X, Sefik E, Stanley III J, Landa B, Strino F, Platt S, Garritano J, Odell I, Coifman R, Flavell R, Myung P, Kluger Y. Gene trajectory inference for single-cell data by optimal transport metrics. Nature Biotechnology 2024, 43: 258-268. PMID: 38580861, PMCID: PMC11452571, DOI: 10.1038/s41587-024-02186-3.
- Pellowe A, Wu M, Kang T, Chung T, Ledesma-Mendoza A, Herzog E, Levchenko A, Odell I, Varga J, Gonzalez A. TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease. American Journal Of Pathology 2024, 194: 1171-1184. PMID: 38548268, PMCID: PMC11220919, DOI: 10.1016/j.ajpath.2024.02.021.
- Odell I, Agrawal K, Sefik E, Odell A, Caves E, Kirkiles-Smith N, Horsley V, Hinchcliff M, Pober J, Kluger Y, Flavell R. IL-6 trans-signaling in a humanized mouse model of scleroderma. Proceedings Of The National Academy Of Sciences Of The United States Of America 2023, 120: e2306965120. PMID: 37669366, PMCID: PMC10500188, DOI: 10.1073/pnas.2306965120.
- Fan R, Johnston MS, Gowen MF, Damsky W, Odell I, Clune J, Vesely MD. Amelanotic melanoma in a patient with Hermansky-Pudlak syndrome. JAAD Case Reports 2022, 27: 61-63. PMID: 35990226, PMCID: PMC9388864, DOI: 10.1016/j.jdcr.2022.06.035.
- Damsky W, Wang A, Kim DJ, Young BD, Singh K, Murphy MJ, Daccache J, Clark A, Ayasun R, Ryu C, McGeary MK, Odell ID, Fazzone-Chettiar R, Pucar D, Homer R, Gulati M, Miller EJ, Bosenberg M, Flavell RA, King B. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature Communications 2022, 13: 3140. PMID: 35668129, PMCID: PMC9170782, DOI: 10.1038/s41467-022-30615-x.
- Xie CB, Ring N, Damsky W, McNiff JM, Olino K, Odell I. Squamous cell carcinoma arising in long-standing necrobiosis lipoidica treated with radical resection and split-thickness skin graft. JAAD Case Reports 2021, 19: 90-93. PMID: 35024397, PMCID: PMC8724883, DOI: 10.1016/j.jdcr.2021.11.005.
- Sun Q, Gehlhausen JR, Freudzon M, Kibbi N, Bale A, Choate K, Tomayko M, Odell I, Ramachandran S. A novel NFkB1 mutation linking pyoderma gangrenosum and common variable immunodeficiency. JAAD Case Reports 2021, 18: 61-63. PMID: 34825039, PMCID: PMC8605275, DOI: 10.1016/j.jdcr.2021.10.015.
- Mendoza H, Goodwin J, Gehlhausen J, Odell I, McNiff J, Gnanapandithan K. New bullous lesions in a 72-year-old woman. Cleveland Clinic Journal Of Medicine 2021, 88: 319-324. PMID: 34078615, DOI: 10.3949/ccjm.88a.20180.
- Olamiju B, Odell I, Panse G, Eder JP, Leventhal JS. Skin puckering and edema during durvalumab therapy. JAAD Case Reports 2020, 7: 110-112. PMID: 33364282, PMCID: PMC7750709, DOI: 10.1016/j.jdcr.2020.11.019.
- Belzer A, Olamiju B, Antaya RJ, Odell ID, Bia M, Perkins SH, Cohen JM. A novel medical student initiative to enhance provision of teledermatology in a resident continuity clinic during the COVID‐19 pandemic: a pilot study. International Journal Of Dermatology 2020, 60: 128-129. PMID: 33226121, PMCID: PMC7753449, DOI: 10.1111/ijd.15322.
- Odell ID, Flavell RA. HER2 joins AKT to inhibit STING immunity. Nature Cell Biology 2019, 21: 917-918. PMID: 31371829, DOI: 10.1038/s41556-019-0368-4.
- Kibbi N, Totonchy M, Suozzi KC, Ko CJ, Odell ID. A case of subungual tumors of incontinentia pigmenti: A rare manifestation and association with bipolar disease. JAAD Case Reports 2018, 4: 737-741. PMID: 30167449, PMCID: PMC6113656, DOI: 10.1016/j.jdcr.2018.03.018.
- Odell ID, Flavell RA. Microbiome: Ecology of eczema. Nature Microbiology 2016, 1: 16135. PMID: 27562264, PMCID: PMC6035744, DOI: 10.1038/nmicrobiol.2016.135.
- Odell ID, Lilly E, Reeve K, Bosenberg MW, Milstone LM. Well-Differentiated Syringofibrocarcinoma in a Patient With Clouston Syndrome. JAMA Dermatology 2016, 152: 484. PMID: 26792110, DOI: 10.1001/jamadermatol.2015.4496.
- Leventhal JS, Odell ID, Imaeda S, Maverakis E, King BA. Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream. JAAD Case Reports 2016, 2: 114-116. PMID: 27051847, PMCID: PMC4810288, DOI: 10.1016/j.jdcr.2016.01.004.
- Shi VJ, Galan A, Odell ID, Choi JN. Cutaneous Vasculopathy as an Adverse Effect of the Anti–Vascular Endothelial Growth Factor Agent Axitinib. JAMA Dermatology 2016, 152: 222. PMID: 26509864, DOI: 10.1001/jamadermatol.2015.3209.
- Lim YH, Odell ID, Ko CJ, Choate KA. Somatic p.T771R KDR (VEGFR2) Mutation Arising in a Sporadic Angioma During Ramucirumab Therapy. JAMA Dermatology 2015, 151: 1240-1243. PMID: 26422291, DOI: 10.1001/jamadermatol.2015.1925.
- Odell ID, Zeidan AM, Parker TL, Colegio OR, Subtil A. Leukaemic vasculitis with myelodysplastic syndrome. The Lancet 2015, 386: 501-502. PMID: 26251396, DOI: 10.1016/s0140-6736(15)61165-5.
- Odell ID, Cook D. Optimizing Direct Immunofluorescence. Methods In Molecular Biology 2014, 1180: 111-117. PMID: 25015144, DOI: 10.1007/978-1-4939-1050-2_6.
- Odell ID, Cook D. Immunofluorescence Techniques. Journal Of Investigative Dermatology 2013, 133: 1-4. PMID: 23299451, DOI: 10.1038/jid.2012.455.
- Odell ID, Wallace SS, Pederson DS. Rules of engagement for base excision repair in chromatin. Journal Of Cellular Physiology 2012, 228: 258-266. PMID: 22718094, PMCID: PMC3468691, DOI: 10.1002/jcp.24134.
- Odell ID, Barbour JE, Murphy DL, Della-Maria JA, Sweasy JB, Tomkinson AE, Wallace SS, Pederson DS. Nucleosome Disruption by DNA Ligase III-XRCC1 Promotes Efficient Base Excision Repair. Molecular And Cellular Biology 2011, 31: 4623-4632. PMID: 21930793, PMCID: PMC3209256, DOI: 10.1128/mcb.05715-11.
- Odell ID, Newick K, Heintz NH, Wallace SS, Pederson DS. Non-specific DNA binding interferes with the efficient excision of oxidative lesions from chromatin by the human DNA glycosylase, NEIL1. DNA Repair 2009, 9: 134-143. PMID: 20005182, PMCID: PMC2829949, DOI: 10.1016/j.dnarep.2009.11.005.
- Hamilton B, Dong Y, Shindo M, Liu W, Odell I, Ruvkun G, Lee SS. A systematic RNAi screen for longevity genes in C. elegans. Genes & Development 2005, 19: 1544-1555. PMID: 15998808, PMCID: PMC1172061, DOI: 10.1101/gad.1308205.
- Odell ID, Cloud JL, Seipp M, Wittwer CT. Rapid Species Identification Within the Mycobacterium chelonae–abscessus Group by High-Resolution Melting Analysis of hsp65 PCR Products. American Journal Of Clinical Pathology 2005, 123: 96-101. PMID: 15762284, DOI: 10.1309/wdr082x9ffjbqqgb.
- Yale DermatologyYale Dermatology - Branford322 East Main StreetBranford, CT 06405
- Photopheresis UnitHunter Building15 York Street, Fl 4thNew Haven, CT 06510
- Yale DermatologyYale Dermatology - Branford322 East Main StreetBranford, CT 06405
- Photopheresis UnitHunter Building15 York Street, Fl 4thNew Haven, CT 06510